| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.1 | 0.07 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.08 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.08 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.09 |